Loading…
Dr. Gater's Weight Loss & Wellness was cited for unlawfully selling unapproved and misbranded compounded drugs (semaglutide and tirzepatide) via their website. The company made false or misleading claims including labeling compounded products as "FDA Approved," falsely describing semaglutide as a "generic version" of Ozempic/Wegovy, and claiming compounded semaglutide was the "generic equivalent" of brand-name products, all in violation of the Federal Food, Drug, and Cosmetic Act sections 502(a) and 502(bb). These marketing practices resulted in unapproved drug products being introduced into interstate commerce without proper regulatory authorization.